Navigation Links
PreMD Reports Fiscal 2007 Results

tives, pending FDA clearance and the subsequent commercialization of our products. We appreciate the patience and support of our stakeholders, as we determine the most effective steps toward enhancing shareholder value while evaluating the opportunities before us."

Financial Review (All amounts are in Canadian dollars)


The consolidated loss for the year ended December 31, 2007 was $6,316,000 or $(0.26) per share compared with a loss of $5,949,000 or $(0.27) per share for the year ended December 31, 2006, an increase of $367,000.

Total product sales of PREVU(x) Skin Cholesterol tests amounted to $41,000 in 2007 compared with $7,000 in 2006. License revenue was $53,000 in 2007 compared to $3,329,000 in 2006, a decrease of $3,276,000. License revenue consists primarily of the upfront cash payments received in accordance with the respective licensing agreements, which have been deferred and recognized into income on a straight-line basis over the terms of the agreements. For 2007, the license revenue represents the amortization of the $533,000 (US$500,000) received upon signing of the license agreement with AstraZeneca on July 13, 2007.

Research and development expenses for the year decreased by $1,996,000 to $2,778,000 from $4,774,000 in 2006. The variance for the year reflects:

- A decrease of $2,224,000 in spending on clinical trials for skin

cholesterol and cancer to $347,000 from $2,571,000 in 2006, following

the submission of the US FDA application;

- An decrease of $103,000 in product liability insurance due which is

related to the reduced number of clinical trials undertaken in 2007;

- An increase of $175,000 in performance-based compensation expense

resulting from achievement of milestones;

- An increase of $88,000 in product development and subcontract

research as related to the vali

Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. PreMD Provides Update on 510(k) Application for PREVU(x) POC
2. PreMD Inc. Provides Corporate Update
3. PreMD Announces Valuable Data on PREVU(x) LT Life Insurance Product
4. PreMD Announces FDA Decision on POC Skin Cholesterol Test
5. PreMD Initiates FDA Review Process and Provides Corporate Update
6. PreMD Inc. Announces Debenture Financing
7. PreMD Inc. Signs Agreement with Cosmetics Conglomerate
8. PreMD Inc. Completes Debenture Financing
9. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
10. Haemacure Reports Third Quarter 2007 Results
11. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
Post Your Comments:
(Date:10/25/2014)... Mesothelioma researchers are reporting extended survival in ... after his combination drug therapy became too toxic. ... posted on the Surviving Mesothelioma website. , A ... Japan suggests that “maintenance therapy” with pemetrexed may be ... tolerate higher doses of cisplatin. , “Although the ...
(Date:10/25/2014)... HealthDay Reporter FRIDAY, Oct. 24, 2014 ... -- herpes simplex -- might increase the risk of Alzheimer,s ... being a carrier of certain antibodies to the virus can ... "The identification of a treatable cause [herpes simplex] of ... researcher Dr. Hugo Lovheim, an associate professor in the department ...
(Date:10/25/2014)... News) -- A large influx of international aid is ... tens of thousands of deaths from the widening Ebola ... Using a specially designed mathematical model, the researchers ... just one densely populated county of hard-hit Liberia -- ... The researchers said that if international aid isn,t ...
(Date:10/25/2014)... (HealthDay News) -- October,s shorter, darker days can trigger ... according to an expert. People affected by ... tired, lack motivation and even have trouble getting out ... suicide, said Dr. Angelos Halaris, a professor in the ... Chicago Stitch School of Medicine. "Seasonal affective disorder ...
(Date:10/22/2014)... 22, 2014 On October 22, CBS ... featuring skin diseases both fictional and real. The ... nonprofit organization committed to advocacy and philanthropy in the ... take the opportunity to impart truth and clarity about ... There are many misconceptions about Morgellons Disease ...
Breaking Medicine News(10 mins):Health News:New Report Illustrates Extended Mesothelioma Survival with “Maintenance Therapy”, According to Surviving Mesothelioma 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3Health News:Experts Predict 'Catastrophic' Ebola Epidemic in West Africa if Aid Delayed 2Health News:Dark Days Here for Folks With Seasonal Depression 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3
... due to use of drugs in northeastern states, Minister ... effective monitoring // and reporting systems in the region ... establish effective drug use monitoring and reporting systems for ... releasing a monograph on the drug use in the ...
... have insurance in the U.S. This shows an increase in ... These individuals between the ages of 19 and 29 are the ... and Rite of Passage neither can figure the reason for no ... not insured at double the rate of adults between 30 – ...
... hospital here, who have been abstaining from duty for ... to introduce reservation in higher education institutions, today went ... whose stir has disrupted medical services in the Swaroop ... hunger strike which they have vowed to continue unless ...
... is usually used to treat insomnia. ,The effects ... of six months by South African researchers//. Neurological rehabilitation experts ... open, awake but unaware of the surroundings, no interaction and ... state. ,Zolpidem was given to the patients ...
... of a woman suffering from domestic violence getting in ... department about the topic. This approach however does not ... reveals a study, published in Archives of Internal Medicine, ... issues prevents many physicians from identifying victims of domestic ...
... U.S. have given an approval for the drug Remicade ... which is a chronic// and debilitating condition. ... that causes diarrhea, fever, abdominal pain, weight loss and, ... it can involve any area of the gastrointestinal tract ...
Cached Medicine News:Health News:No Insurance For Young Adults In U.S. 2Health News:No Insurance For Young Adults In U.S. 3Health News:Discussion On Domestic Violence Increased By Computer Based Screening 2Health News:Discussion On Domestic Violence Increased By Computer Based Screening 3Health News:Arthritic Drug Approved For Use In Children With Crohn’s Diseas 2
(Date:10/25/2014)... 24, 2014  America,s future engineers will connect ... at the  Medical Design and Manufacturing (MD&M) Minneapolis ... at the Minneapolis ... built robots from the "For Inspiration and Recognition ... and mentors will offer information to those curious ...
(Date:10/25/2014)... 2014  The National Association of Drug Diversion ... by Kentucky,s real-time, stop-sale ... National Precursor Log Exchange (NPLEx) system automatically blocks ... and helps flag meth offenders for law enforcement. ... NPLEx "watch lists" that notify them via email ...
(Date:10/25/2014)... Oct. 24, 2014 In conjunction with DURECT ... financial results press release, you are invited to listen ... over the internet on Monday, November 3, 2014 at ... A live audio webcast of the presentation will ... and clicking "Investor Relations."  If you are unable ...
Breaking Medicine Technology:Local robotics teams compete - a "FIRST" at next week's MD&M Minneapolis- October 29-30th at the Minneapolis Convention Center 2Local robotics teams compete - a "FIRST" at next week's MD&M Minneapolis- October 29-30th at the Minneapolis Convention Center 3Kentucky's NPLEx Technology Making Significant Progress 2DURECT Corporation Invites You to Join its Third Quarter 2014 Earnings Conference Call 2
... Leica M844 F40 with its new stand F19 ... allow on the one hand to homogenously move ... operate with a solid and stable microscope. The ... Chrome optics, stands on the same small footprint ...
... 2000 assays are designed ... IMMULITE 2000, a high-throughput, ... analyzer. IMMULITE 2000 offers ... and a rapidly expanding ...
... Detection Of Serum C-Peptide ... Measurement:, Evaluating patients ... Assisting in the classification ... Differentiating insulin dependent patients ...
Medicine Products: